TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Renal Cancer Drug Market, by Therapeutic Class
6.1 Introduction
6.2 Targeted Therapy
6.3 ImmunoTherapy
Chapter 7. Global Renal Cancer Drug Market, by Pharmacologic Class
7.1 Introduction
7.2 Angiogenesis Inhibitors
7.3 mTOR Inhibitors
7.4 Monoclonal Antibodies
7.5 Cytokine Immunotherapy (IL-2)
Chapter 8. Global Renal Cancer Drug Market, by Type
8.1 Clear Cell
8.2 Papillary
8.3 Chromophobe
8.4 Oncocytic
8.5 Collecting Duct
8.6 Other
Chapter 9 Global Renal Cancer Drug Market, by End-Users
9.1 Introduction
9.2 Hospitals and clinics
9.3 Ambulatory Surgical Centers
9.4 Diagnostic Centers
9.5 Research centers
9.6 Others
Chapter 10. Global Renal Cancer Drug Market, by Region
10.1 Introduction
10.2 America
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
Chapter 12 Company Profiles
12.1 Active Biotech AB
12.1.1 Company Overview
12.1.2 End-Users Overview
12.1.3 Financials
12.2.4 Key Developments
12.1.5 SWOT Analysis
12.2 Amgen
12.2.1 Company Overview
12.2.2 End-Users Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 GlaxoSmithKline Plc.
12.3.1 Company Overview
12.3.2 End-Users Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Genentech, Inc.
12.4.1 Company Overview
12.4.2 End-Users/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 F. Hoffmann-La Roche AG
12.5.1 Company Overview
12.5.2 End-Users Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 Cipla Limited
12.6.1 Company Overview
12.6.2 End-Users Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
11.7 Active Biotech AB
12.7.1 Overview
12.7.2 End-Users Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 AMGEN
12.8.1 Overview
12.8.2 End-Users Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 Bayer AG
12.9.1Overview
12.8.2 End-Users Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.10 Bristol-Myers Squibb company
12.10.1Overview
12.10.2 End-Users Overview
12.10.3 Financials
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.12 Others
Chapter 13 Appendix
LIST OF TABLES
Table 1 Global Renal Cancer Drug Market Industry Synopsis, 2020–2027
Table 2 Global Renal Cancer Drug Market Estimates & Forecast, 2020–2027, (USD Million)
Table 3 Global Renal Cancer Drug Market, by Region, 2020–2027, (USD Million)
Table 4 Global Renal Cancer Drug Market, by Therapeutic Class, 2020–2027, (USD Million)
Table 5 Global Renal Cancer Drug Market, by Pharmacologic Class, 2020–2027, (USD Million)
Table 6 Global Renal Cancer Drug Market, by Type, 2020–2027, (USD Million)
Table 7 Global Renal Cancer Drug Market, by End-Users, 2020–2027, (USD Million)
Table 8 North America: Global Renal Cancer Drug Market, by Therapeutic Class, 2020–2027, (USD Million)
Table 9 North America: Global Renal Cancer Drug Market, by Pharmacologic Class, 2020–2027, (USD Million)
Table 10 North America: Global Renal Cancer Drug Market, by Type, 2020–2027, (USD Million)
Table 11 North America: Global Renal Cancer Drug Market, by End-Users, 2020–2027, (USD Million)
Table 12 US: Global Renal Cancer Drug Market, by Therapeutic Class, 2020–2027, (USD Million)
Table 13 US: Global Renal Cancer Drug Market, by Pharmacologic Class, 2020–2027, (USD Million)
Table 14 US: Global Renal Cancer Drug Market, by Type, 2020–2027, (USD Million
Table 15 US: Global Renal Cancer Drug Market, by End-Users, 2020–2027, (USD Million)
Table 16 Canada: Global Renal Cancer Drug Market, by Therapeutic Class, 2020–2027, (USD Million)
Table 17 Canada: Global Renal Cancer Drug Market, by Pharmacologic Class, 2020–2027, (USD Million)
Table 18 Canada: Global Renal Cancer Drug Market, by Type, 2020–2027, (USD Million)
Table 19 Canada: Global Renal Cancer Drug Market, by End-Users, 2020–2027, (USD Million)
Table 20 South America: Global Renal Cancer Drug Market, by Therapeutic Class, 2020–2027, (USD Million)
Table 21 South America: Global Renal Cancer Drug Market, by Pharmacologic Class, 2020–2027, (USD Million)
Table 22 South America: Global Renal Cancer Drug Market, by Type, 2020–2027, (USD Million)
Table 23 South America: Global Renal Cancer Drug Market, by End-Users, 2020–2027, (USD Million)
Table 24 Europe: Global Renal Cancer Drug Market, Therapeutic Class, 2020–2027, (USD Million)
Table 25 Europe: Global Renal Cancer Drug Market, by Pharmacologic Class, 2020–2027, (USD Million)
Table 26 Europe: Global Renal Cancer Drug Market, by Type, 2020–2027, (USD Million)
Table 27 Europe: Global Renal Cancer Drug Market, by End-Users, 2020–2027, (USD Million)
Table 28 Western Europe: Global Renal Cancer Drug Market, by Therapeutic Class, 2020–2027, (USD Million)
Table 29 Western Europe: Global Renal Cancer Drug Market, by Pharmacologic Class, 2020–2027, (USD Million)
Table 30 Western Europe: Global Renal Cancer Drug Market, by Type, 2020–2027, (USD Million)
Table 31 Western Europe: Global Renal Cancer Drug Market, by End-Users, 2020–2027, (USD Million)
Table 32 Eastern Europe: Global Renal Cancer Drug Market, by Therapeutic Class, 2020–2027, (USD Million)
Table 33 Eastern Europe: Global Renal Cancer Drug Market, by Pharmacologic Class, 2020–2027, (USD Million)
Table 34 Eastern Europe: Global Renal Cancer Drug Market, by Type, 2020–2027, (USD Million)
Table 35 Eastern Europe: Global Renal Cancer Drug Market, by End-Users, 2020–2027, (USD Million)
Table 36 Asia-Pacific: Global Renal Cancer Drug Market, by Therapeutic Class, 2020–2027, (USD Million)
Table 37 Asia-Pacific: Global Renal Cancer Drug Market, by Pharmacologic Class, 2020–2027, (USD Million)
Table 38 Asia-Pacific: Global Renal Cancer Drug Market, by Type, 2020–2027, (USD Million)
Table 39 Asia-Pacific: Global Renal Cancer Drug Market, by End-Users, 2020–2027, (USD Million)
Table 31 Middle East & Africa: Global Renal Cancer Drug Market, by Therapeutic Class,2020-2027,(USD Million)
Table 32 Middle East & Africa: Global Renal Cancer Drug Market, by Pharmacologic Class, 2020–2027, (USD Million)
Table 33 Middle East & Africa: Global Renal Cancer Drug Market, by Type, 2020–2027, (USD Million)
Table 34 Middle East & Africa: Global Renal Cancer Drug Market, by End-Users, 2020–2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for the Global Renal Cancer Drug Market
Figure 3 Market Dynamics for the Global Renal Cancer Drug Market
Figure 4 Global Renal Cancer Drug Market Share, by Therapeutic Class 2020
Figure 6 Global Renal Cancer Drug Market Share, by Pharmacologic Class, 2020
Figure 7 Global Renal Cancer Drug Market Share, by Type, 2020
Figure 8 Global Renal Cancer Drug Market Share, by End-Users, 2020
Figure 9 Global Renal Cancer Drug Market Share, by Region, 2020
Figure 10 North America Global Renal Cancer Drug Market Share, by Country, 2020
Figure 11 Europe Prescribed Health Apps Share, by Country, 2020
Figure 12 Asia-Pacific Global Renal Cancer Drug Market Share, by Country, 2020
Figure 13 Middle East & Africa Global Renal Cancer Drug Market Share, by Country, 2020
Figure 14 Global Renal Cancer Drug Market: Company Share Analysis, 2020 (%)
Figure 15 Novartis AG: Key Financials
Figure 16 Novartis AG: Segmental Revenue
Figure 17 Novartis AG: Geographical Revenue
Figure 18 Pfizer Inc.: Key Financials
Figure 19 Pfizer Inc.: Segmental Revenue
Figure 20 Pfizer Inc.: Geographical Revenue
Figure 21 GlaxoSmithKline plc: Key Financials
Figure 22 GlaxoSmithKline plc.: Segmental Revenue
Figure 23 GlaxoSmithKline plc.: Geographical Revenue
Figure 24 Genentech, Inc.: Key Financials
Figure 25 Genentech, Inc.: Segmental Revenue
Figure 26 Genentech, Inc.: Geographical Revenue
Figure 27 F. Hoffmann-La Roche AG: Key Financials
Figure 28 F. Hoffmann-La Roche AG: Segmental Revenue
Figure 29 F. Hoffmann-La Roche AG: Geographical Revenue
Figure 30 Cipla Limited: Key Financials
Figure 31 Cipla Limited: Segmental Revenue
Figure 32 Cipla Limited: Geographical Revenue
Figure 33 Active Biotech AB: Key Financials
Figure 34 Active Biotech AB: Segmental Revenue
Figure 35 Active Biotech AB: Geographical Revenue
Figure 36 Amgen: Key Financials
Figure 37 Amgen: Segmental Revenue
Figure 38 Amgen: Geographical Revenue
Figure 39 Bayer AG: Key Financials
Figure 40 Bayer AG: Segmental Revenue
Figure 41 Bayer AG: Geographical Revenue
Figure 42 Bristol-Myers Squibb company: Key Financials
Figure 43 Bristol-Myers Squibb company: Segmental Revenue
Figure 44 Bristol-Myers Squibb company: Geographical Revenue
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
